Pfizer’s New Bladder Cancer Therapy Shows Promising Results in Late-Stage Trials!
Pfizer has announced encouraging results from a late-stage study of its experimental treatment for a form of bladder cancer. The treatment, a combination of an antibody called sasanlimab and the...